Literature DB >> 7202056

A representative value for whole-day BP monitoring.

M A Weber, J I Drayer, F A Wyle, D D Brewer.   

Abstract

Shorter-term alternatives to 24-hour monitoring of BP were analyzed in six hypertensive patients. Average BPs during the 24-hour period were lower than averages during a two-hour morning period or those based on either three readings or a single reading taken at 8 AM. The systolic and diastolic BP two-hour averages correlated more strongly with the 24-hour averages than did the three-reading or single-reading alternatives. Thus, the average of serial BP readings obtained during a two-hour morning period is a consistent predictor of the whole-day BP and represents it more closely than the conventionally used single reading.

Entities:  

Mesh:

Year:  1982        PMID: 7202056

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  4 in total

1.  Indication-specific 6-h systolic blood pressure thresholds can approximate 24-h determination of blood pressure control.

Authors:  M E Ernst; G S Sezate; W Lin; C A Weber; J D Dawson; B L Carter; G R Bergus
Journal:  J Hum Hypertens       Date:  2010-06-24       Impact factor: 3.012

2.  Intermittent ambulatory blood pressure recordings in children. Methodological aspects and influence of family history on hypertension.

Authors:  H Neus; E Gogolin; W Langewitz; A W von Eiff
Journal:  Klin Wochenschr       Date:  1984-11-02

3.  Is it possible to shorten ambulatory blood pressure monitoring?

Authors:  Talya Wolak; Lior Wilk; Esther Paran; Arik Wolak; Bella Gutmacher; Elena Shleyfer; Michael Friger
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-06-04       Impact factor: 3.738

4.  How well does a shortened time interval characterize results of a full ambulatory blood pressure monitoring session?

Authors:  Michael E Ernst; Cynthia A Weber; Jeffrey D Dawson; Michelle A O'Connor; Wenjiao Lin; Barry L Carter; George R Bergus
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-06       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.